Myeloproliferative Neoplasms (Record no. 106357)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03480nam a22005175i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-60761-266-7 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083734.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 101029s2011 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781607612667 |
| -- | 978-1-60761-266-7 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-60761-266-7 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RB45 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJF |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED038000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.15 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Verstovsek, Srdan. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Myeloproliferative Neoplasms |
| Medium | [electronic resource] : |
| Remainder of title | Biology and Therapy / |
| Statement of responsibility, etc | edited by Srdan Verstovsek, Ayalew Tefferi. |
| 264 #1 - | |
| -- | Totowa, NJ : |
| -- | Humana Press : |
| -- | Imprint: Humana Press, |
| -- | 2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | X, 230 p. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Contemporary Hematology |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 1 - Diagnosis and Classification of the BCR-ABL-negative Myeloproliferative Neoplasms -- Chapter 2 - Genetics of the Myeloproliferative Neoplasms -- Chapter 3 - Cytogenetic Findings in Classic Myeloproliferative Neoplasms -- Chapter 4 - Prognostic Factors in Classic Myeloproliferative Neoplasms -- Chapter 5 - Therapy of Polycythemia Vera and Essential Thrombocythemia -- Chapter 6 - Conventional and Investigational Therapy for Primary Myelofibrosis -- Chapter 7 - Hematopoietic Cell Transplantation for Myelofibrosis -- Chapter 8 - JAK2 Inhibitors as Therapy for Classic Myeloproliferative Neoplasms -- Chapter 9 - Blastic Transformation of Classic Myeloproliferative Neoplasms -- Chapter 10 - Eosinophilic Disorders: Differential Diagnosis and Management -- Chapter 11 - Pathogenesis, Diagnosis, Classification, and Management of Systemic Mastocytosi. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | This succinct resource provides an ideal balance of the biology and practical therapeutic strategies for classic and non-classic BCR-ABL-negative myeloproliferative neoplasms. Utilizing current World Health Organization nomenclature, classification, and diagnostic criteria, international experts have assembled to convey the most up-to-date knowledge in this rapidly evolving field. The opening chapters cover the diagnosis and classification, genetics, cytogenetic findings, and prognostic factors of MPNs. Further chapters explore therapies specific to the different disease entities, including polycythemia vera, essential thrombocytopenia, myelofibrosis, and eosinophilic disorders, and mastocytosis. Unique areas of discussion include JAK2 inhibitor therapy, hematopoietic stem cell transplantation, and blastic transformation. A valuable reference for practicing hematologists, this forefront book enriches our understanding of recent discoveries and their impact on conventional and investigational treatments. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Angiography. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Hematology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biochemistry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Hematology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Angiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical Biochemistry. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tefferi, Ayalew. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781607612650 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Contemporary Hematology |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-60761-266-7 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.